Search Results 51-60 of 12575 for 5-Amino-1MQ

  1. An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation In PSMA Positive OMPC. (PSMA-DC) - Mayo Clinic

    positive OMPC with 1 to 5 metastatic lesions ... 5. Histologically confirmed prostate cancer prior ... steroidogenesis inhibitors (aminoglutethamide); - ...

  2. Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma - Mayo Clinic

    Serum M-protein ≥ 0.5 g/dL (≥ 5 g/L);; Urine M-protein ≥ 200 mg/24 h;; Serum FLC assay: Involved FLC level ≥10 mg/dL (≥100 mg/L) and an abnormal serum ...

  3. A Study Of MT-5111 In HER2-positive Solid Tumors - Mayo Clinic

    AST ≤ 3 x ULN and ALT ≤ 3 x ULN - < 5 x ULN (if hepatic metastases). Exclusion Criteria: History or current evidence of another tumor that is ...

  4. PRGN-3006 Adoptive Cellular Therapy For CD33-Positive Relapsed Or Refractory AML, MRD Positive AML Or Higher Risk MDS - Mayo Clinic

    Participants enrolled in another investigational therapy protocol for their disease within 14 days or 5 half-lives of enrollment, whichever is shorter.

  5. Ivosidenib, Nivolumab, And Ipilimumab Combination In Previously Treated Subjects With Nonresectable Or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

    ... 5 months after the last dose of study treatment. Ivosidenib, nivolumab, and ipilimumab may have adverse effects on a fetus in utero. Furthermore, it is not ...

  6. Mayo Clinic

    3663200_0071R_6col · Print. Sections. Products and services. The Mayo Clinic Diet: What is your weight-loss goal? 5-10. Because proton beam therapy was close to ...

  7. Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza - Mayo Clinic

    ... amino acid substitutions per year. Reconstruction of the sequence of the hypothetical ancestral strain at the avian-human transition indicated that only 6 amino ...

  8. Rem-422, An MYB MRNA Degrader, In Patients With Relapsed/Refractory AML Or Higher-Risk MDS - Mayo Clinic

    Use of strong CYP3A inhibitors (except azole antifungals) or CYP3A inducers < 7 days or < 5 half-lives, whichever is longer, prior to initiating REM-422 ...

  9. Hematology - Clinical trials

    This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back (recurrent) or ...

  10. Aminophylline (intravenous route) - Side effects & uses - Mayo Clinic

    Bronchodilators are medicines that relax the muscles in the bronchial tubes (air passages) of the lungs. They relieve cough, wheezing, shortness of breath, and ...